Giovanna Zambruno Selected Research

Epidermolysis Bullosa

1/2024	Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.
5/2014	Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.
4/2010	Molecular testing in epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Zambruno Research Topics

Disease

9	Neoplasms (Cancer) 01/2024 - 01/2002
8	Bullous Pemphigoid (Pemphigoid) 04/2012 - 01/2004
7	Netherton Syndrome 05/2012 - 02/2002
7	Melanoma (Melanoma, Malignant) 07/2008 - 01/2002
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2024 - 12/2005
5	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 11/2021 - 09/2003
5	Ichthyosis (Xeroderma) 10/2020 - 09/2014
5	Pemphigus (Pemphigus Vulgaris) 01/2019 - 12/2008
4	Wounds and Injuries (Trauma) 11/2015 - 10/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 05/2014
3	Epidermolysis Bullosa 01/2024 - 04/2010
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2021 - 09/2006
3	Poikiloderma of Kindler 01/2013 - 01/2004
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2021
2	Fibrosis (Cirrhosis) 05/2021 - 01/2019
2	Trichothiodystrophy Syndromes 01/2021 - 02/2015
2	X-Linked Ichthyosis (Ichthyosis, X Linked) 10/2019 - 07/2019
2	Premature Aging 01/2019 - 04/2010
2	Inflammation (Inflammations) 01/2019 - 01/2011
2	Cicatrix (Scar) 12/2015 - 02/2007
2	Exfoliative Dermatitis (Erythroderma) 09/2015 - 02/2002
2	Zlotogora-Ogur syndrome 08/2014 - 08/2010
2	Syndactyly (Polysyndactyly) 08/2014 - 08/2010
2	Cleft Lip (Harelip) 08/2014 - 08/2010
2	Ectodermal Dysplasia (Aplasia Cutis Congenita) 08/2014 - 08/2010
2	Hyperplasia 07/2012 - 06/2007
2	Skin Diseases (Skin Disease) 01/2011 - 04/2007
2	Autoimmune Diseases (Autoimmune Disease) 04/2010 - 12/2008
2	Pathologic Neovascularization 08/2006 - 01/2006
2	Neoplasm Metastasis (Metastasis) 08/2006 - 08/2003
1	Linear IgA Bullous Dermatosis 02/2024
1	COVID-19 01/2023
1	Lymphopenia (Lymphocytopenia) 01/2023
1	Reinfection 01/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2022
1	Diarrhea 01/2022
1	Ataxia (Dyssynergia) 11/2021
1	Deafness (Deaf Mutism) 11/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Erythema 01/2021
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2021
1	Nevus (Nevi) 10/2020
1	Cockayne Syndrome (Syndrome, Cockayne) 01/2019
1	Foot Deformities (Foot Deformity) 01/2019
1	Blister (Bulla) 01/2019
1	Disease Progression 01/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Genetic Skin Diseases 07/2017

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
9	AutoantibodiesIBA 01/2019 - 01/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2006
5	Collagen Type VIIIBA 11/2021 - 12/2005
5	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2012 - 01/2005
4	EnzymesIBA 01/2024 - 01/2007
4	EpitopesIBA 11/2011 - 01/2004
4	AntigensIBA 04/2010 - 02/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2007 - 01/2006
3	Keratins (Keratin)IBA 01/2022 - 11/2004
3	Placenta Growth FactorIBA 10/2006 - 01/2006
3	Serine Peptidase Inhibitor Kazal-Type 5IBA 07/2006 - 02/2002
2	UbiquitinIBA 01/2022 - 11/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021 - 12/2015
2	Protein Isoforms (Isoforms)IBA 11/2021 - 02/2006
2	Laminin (Merosin)IBA 11/2021 - 11/2016
2	Collodion (Nitrocellulose)IBA 01/2021 - 09/2015
2	Nonsense Codon (Nonsense Mutation)IBA 07/2019 - 09/2011
2	DesmogleinsIBA 01/2019 - 10/2012
2	Keratin-14 (Keratin 14)IBA 12/2015 - 08/2006
2	Messenger RNA (mRNA)IBA 11/2015 - 10/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 08/2003
2	Streptozocin (Streptozotocin)FDA Link 11/2015 - 10/2006
2	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2015 - 04/2010
2	Immunoglobulin E (IgE)IBA 01/2015 - 02/2002
2	NectinsIBA 08/2014 - 08/2010
2	IntegrinsIBA 09/2013 - 01/2013
2	Peptide Hydrolases (Proteases)FDA Link 10/2012 - 01/2005
2	CollagenIBA 04/2012 - 01/2002
2	Vascular Endothelial Growth Factor CIBA 06/2007 - 08/2003
2	Matrix Metalloproteinases (MMPs)IBA 02/2007 - 08/2006
2	Temozolomide (Temodar)FDA LinkGeneric 10/2006 - 06/2004
2	KalininIBA 10/2004 - 09/2003
1	Immunoglobulin A (IgA)IBA 02/2024
1	Immune Checkpoint ProteinsIBA 01/2024
1	Gamma Secretase Inhibitors and ModulatorsIBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Ligases (Synthetase)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 11/2021
1	Extracellular Matrix ProteinsIBA 05/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 10/2019
1	AutoantigensIBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	DecorinIBA 01/2019

Therapy/Procedure

4	Therapeutics 11/2021 - 07/2012
2	Immunotherapy 01/2024 - 12/2008
1	Parenteral Nutrition 01/2022